Equitable Trust’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-23,885
| Closed | -$1.5M | – | 473 |
|
2024
Q3 | $1.5M | Sell |
23,885
-5,158
| -18% | -$324K | 0.1% | 158 |
|
2024
Q2 | $1.72M | Sell |
29,043
-5,213
| -15% | -$308K | 0.12% | 144 |
|
2024
Q1 | $2.73M | Buy |
34,256
+6,974
| +26% | +$556K | 0.19% | 107 |
|
2023
Q4 | $2.15M | Buy |
27,282
+11,128
| +69% | +$879K | 0.16% | 117 |
|
2023
Q3 | $1.13M | Buy |
16,154
+6,917
| +75% | +$483K | 0.09% | 153 |
|
2023
Q2 | $639K | Hold |
9,237
| – | – | 0.05% | 226 |
|
2023
Q1 | $686K | Buy |
9,237
+2,345
| +34% | +$174K | 0.05% | 213 |
|
2022
Q4 | $642K | Hold |
6,892
| – | – | 0.05% | 228 |
|
2022
Q3 | $657K | Sell |
6,892
-148
| -2% | -$14.1K | 0.05% | 213 |
|
2022
Q2 | $653K | Sell |
7,040
-74
| -1% | -$6.86K | 0.05% | 222 |
|
2022
Q1 | $720K | Buy |
7,114
+186
| +3% | +$18.8K | 0.05% | 205 |
|
2021
Q4 | $715K | Sell |
6,928
-867
| -11% | -$89.5K | 0.04% | 204 |
|
2021
Q3 | $662K | Buy |
7,795
+312
| +4% | +$26.5K | 0.04% | 213 |
|
2021
Q2 | $625K | Buy |
7,483
+179
| +2% | +$15K | 0.04% | 225 |
|
2021
Q1 | $550K | Buy |
7,304
+1,651
| +29% | +$124K | 0.04% | 235 |
|
2020
Q4 | $386K | Buy |
5,653
+1,900
| +51% | +$130K | 0.03% | 266 |
|
2020
Q3 | $219K | Sell |
3,753
-70
| -2% | -$4.09K | 0.02% | 302 |
|
2020
Q2 | $249K | Sell |
3,823
-695
| -15% | -$45.3K | 0.02% | 285 |
|
2020
Q1 | $268K | Sell |
4,518
-805
| -15% | -$47.8K | 0.03% | 267 |
|
2019
Q4 | $395K | Sell |
5,323
-748
| -12% | -$55.5K | 0.04% | 218 |
|
2019
Q3 | $383K | Sell |
6,071
-183
| -3% | -$11.5K | 0.04% | 210 |
|
2019
Q2 | $341K | Buy |
6,254
+261
| +4% | +$14.2K | 0.04% | 222 |
|
2019
Q1 | $323K | Sell |
5,993
-17,407
| -74% | -$938K | 0.04% | 231 |
|
2018
Q4 | $1.53M | Buy |
23,400
+18,621
| +390% | +$1.22M | 0.2% | 112 |
|
2018
Q3 | $377K | Sell |
4,779
-5,861
| -55% | -$462K | 0.04% | 226 |
|
2018
Q2 | $685K | Buy |
+10,640
| New | +$685K | 0.09% | 165 |
|